We joined 46 other cancer charities to outline what we need from UK Governments and the NHS coming out of the pandemic to move towards world-leading services.
The latest cancer waiting times show an 8% drop in the number of people starting cancer treatment in January, compared with figures from January 2020.
A potentially life-extending treatment for some people with non small cell lung cancer (NSCLC) will now be available on the NHS in England.
There’s been a steady stream of figures since the pandemic began, each laying bare what many people have seen first-hand – the impact on health services.
The three latest SMC decisions will provide new treatment options for some adults with non small cell lung cancer, multiple myeloma and a rare type of lymphoma.
Lymphoma patients in England are among the first in the world to be offered new CAR T cell therapy.
A new targeted treatment has been recommended by the National Institute of Health and Care Excellence for some adults with ovarian cancer.
The Scottish Medicines Consortium (SMC) has approved a new chemotherapy-free treatment option for some adults with untreated chronic lymphocytic leukaemia.
Confusion over the symptoms of lung cancer and COVID-19 may be responsible for a drop in the number of people being referred for lung cancer tests in Wales.